West Pharmaceutical Services Files Q1 2026 10-Q
Ticker: WST · Form: 10-Q · Filed: Apr 23, 2026 · CIK: 0000105770
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
WEST PHARMA FILES Q1 10-Q. FINANCIALS OUT.
AI Summary
West Pharmaceutical Services Inc. filed its quarterly report (10-Q) on April 23, 2026, for the period ending March 31, 2026. The filing includes financial statements and exhibits related to its operations. The company's mailing and business address is 530 Herman O. West Drive, Exton, PA 19341.
Why It Matters
This filing provides investors and analysts with an update on West Pharmaceutical Services' financial performance and operational status for the first quarter of 2026.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Numbers
- 1263385 — iXBRL 10-Q Size (Size of the main interactive data document.)
- 8944591 — Complete submission text file Size (Total size of the complete submission text file.)
Key Players & Entities
- WEST PHARMACEUTICAL SERVICES INC (company) — Filer
- 0000105770 (company) — CIK
- 2026-04-23 (date) — Filing Date
- 2026-03-31 (date) — Period of Report
- 530 HERMAN O. WEST DRIVE EXTON PA 19341 (location) — Mailing and Business Address
FAQ
What is the CIK number for West Pharmaceutical Services Inc.?
The CIK number for West Pharmaceutical Services Inc. is 0000105770.
When was this 10-Q filing accepted by the SEC?
This 10-Q filing was accepted on 2026-04-23.
What period does this quarterly report cover?
This quarterly report covers the period ending 2026-03-31.
What is the company's primary business address?
The company's business address is 530 Herman O. West Drive, Exton, PA 19341.
What is the file number for this filing?
The file number for this filing is 001-08036.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 23, 2026 regarding WEST PHARMACEUTICAL SERVICES INC (WST).